98%
921
2 minutes
20
Objective: To investigate the association between ABO blood types and gestational diabetes mellitus (GDM) risk.
Methods: A prospective birth cohort study was conducted. ABO blood types were determined using the slide method. GDM diagnosis was based on a 75-g, 2-h oral glucose tolerance test (OGTT) according to the criteria of the International Association of Diabetes and Pregnancy Study Groups. Logistic regression was applied to calculate the odds ratios ( s) and 95% confidence intervals ( s) between ABO blood types and GDM risk.
Results: A total of 30,740 pregnant women with a mean age of 31.81 years were enrolled in this study. The ABO blood types distribution was: type O (30.99%), type A (26.58%), type B (32.20%), and type AB (10.23%). GDM was identified in 14.44% of participants. Using blood type O as a reference, GDM risk was not significantly higher for types A ( = 1.05) or B ( = 1.04). However, women with type AB had a 19% increased risk of GDM ( = 1.19, 95% = 1.05-1.34; < 0.05), even after adjusting for various factors. This increased risk for type AB was consistent across subgroup and sensitivity analyses.
Conclusion: The ABO blood types may influence GDM risk, with type AB associated with a higher risk. Incorporating it-either as a single risk factor or in combination with other known factors-could help identify individuals at risk for GDM before or during early pregnancy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3967/bes2025.046 | DOI Listing |
J Heart Lung Transplant
September 2025
Professor of Pediatrics and Immunology, Director Pediatric Cardiac Transplantation, University of Alberta / Stollery Children's Hospital, 4C2.24, Walter MacKenzie Center, 8440 - 112 Street, Edmonton, AB, T6G 2B7. Electronic address:
J Med Cases
August 2025
Hematology and Oncology Service, Hospital Privado Universitario de Cordoba, Argentina.
Pure red cell aplasia (PRCA) is a potential complication after ABO-incompatible allogeneic hematopoietic stem cell transplantation (HCT). In case where PRCA persists beyond 60 days post-HCT, spontaneous resolution is rare, and therapeutic intervention is typically required. However, there is currently no established standard of care for its management.
View Article and Find Full Text PDFInt J Gen Med
August 2025
Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Eastern Province, Saudi Arabia.
Background: The global vaccination campaign against COVID-19 has necessitated monitoring vaccine-related adverse events among healthcare workers. This study aims to elucidate the relationship between ABO blood groups and the prevalence and perception of post-vaccination symptoms in this cohort.
Methods: A cross-sectional survey was conducted among 379 healthcare workers to collect demographic data, blood group information, vaccination status, symptom onset and duration, the impact of symptoms on work, and the efficacy of symptom relief measures.
Ren Fail
December 2025
Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Background: Tacrolimus is key in renal transplantation. This study evaluated optimal intrapatient variability (IPV) and time in therapeutic range (TTR) thresholds and association with renal outcomes.
Methods: This single-center study (1999-2018) had a mean follow-up of 3 years.
Blood Transfus
August 2025
Blood Group Reference Laboratory, Institute of Blood Transfusion, Shanghai Blood Center, Shanghai, China.